Viewing Study NCT05683457


Ignite Creation Date: 2025-12-24 @ 6:56 PM
Ignite Modification Date: 2026-01-02 @ 4:18 AM
Study NCT ID: NCT05683457
Status: RECRUITING
Last Update Posted: 2025-03-13
First Post: 2023-01-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Allogenic Hematopoietic Cell Transplantation (HCT) Participants.
Sponsor: ModernaTX, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-04-05
Start Date Type: ACTUAL
Primary Completion Date: 2026-08-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2026-08-01
Completion Date Type: ESTIMATED
First Submit Date: 2023-01-04
First Submit QC Date: None
Study First Post Date: 2023-01-13
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-03-12
Last Update Post Date: 2025-03-13
Last Update Post Date Type: ACTUAL